Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung

7680632950015 CH-63295 Pulver
Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung
Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
28/05/2025
Summary of Product Characteristics
Français
28/05/2025
Summary of Product Characteristics
Italien
28/05/2025

Detailed composition

Substance Quantity Type Category
PRC
150.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HIMDK
PRC
- Substance HIMDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 602.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2017

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
63295
Drug name
Cosentyx, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
L04AC10
Authorization status
Z
Dispensing category
B
First authorization
20/02/2015
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque Psoriasis bei Erwachsenen und Kindern ab 6 Jahren, ankylosierende Spondylitis, psoriatische Arthritis, nicht-röntgenologische axiale Spondyloarthritis, Hidradenitis suppurativa

Package details

Description (FR)
COSENTYX subst sèche 150 mg flac
Description (DE)
COSENTYX Trockensub 150 mg Durchstf
Market launch
20/02/2015
Narcotic (BTM)
No